Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs

Veterinary Record

Volumn 161, Issue 13, 2007, Pages 444-447

  Benchaoui, H A ^a   Siedek, E M ^a   De La Puente Redondo, V A ^a   Tilt, N ^a   Rowan, T G ^a   Clemence, R G ^a  

^a ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 35349023283     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.161.13.444     Document Type: Article

References (16)

1. BENCHAOUI, H. A., COX, S. R., SCHNEIDER, R. P., BOUCHER, J. F. & CLEMENCE, R. G. (2007) The pharmokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs. Journal of Veterinary Pharmacology and Therapeutics 30, 336-344
2. BORISON, H. L. (1985) A misconception of motion sickness leads to false therapeutic expectations. Aviation, Space and Environmental Medicine 56, 66-68
3. BORISON, H. L. & BORISON, R. (1986) Motion sickness reflex arc bypasses the area postrema. Experimental Neurology 92, 723-737
4. CHEUNG, B. S., MONEY, K. E., KOHL, R. L. & KINTER, L. B. (1992) Investigation of anti-motion sickness drugs in the squirrel monkey. Journal of Clinical Pharmacology 32, 163-175
5. DIEMUNSCH, P. & GRÉLOT, L. (2000) Potential of substance P antagonists as antiemetics. Drugs 60, 533-546
6. 1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs. Neuroscience Research 33, 25-32
7. 1 receptor, and potent broad-spectrum anti-emetic activity. Regulatory Peptides 65, 45-53
8. LEONARD, E. A., PULLEN, C. M., EUSE, V. L., MARTIN, J. J., RADAR, F. L., OSGOOD, N. L., DAVIS, P. D., SANDERS, B. C., HUDSON, D. A. & REILLY, D. R. (1978) Motion sickness in dogs and cats. Modern Veterinary Practice 56, 639-640
9. LUCOT, J. B., OBACH, R. S., MCLEAN, S. & WATSON, J. W. (1997) The effect of CP-99994 on the responses to provocative motion in the cat. British Journal of Pharmacology 120, 116-120
10. MURDOCH, D. B. (1984) Alimentary tract and associated glands. In Canine Medicine and Therapeutics. 2nd edn. Eds E. A. Chandler, J. B. Sutton, D. J. Thompson. Oxford, Blackwell Scientific for BSAVA. p 373
11. SCHMÄL, F. & STOLL, W. (2003) Neuronal mechanisms and treatment of motion sickness. In Antiemetic Therapy. 1st edn. Ed J. Donnerer. Basel, Karger. pp 98-112
12. TWEDT, D. C. (2000) Vomiting. In Textbook of Veterinary Internal Medicine. 5th edn. Eds S. J. Ettinger, E. C. Feldman. Philadelphia, W. B. Saunders. pp 117-121
13. VICH (2000) International Co-operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products, Good Clinical Practice, June 2000, effective July 1, 2001
14. WASHABAU, R. J. & ELIE, M. S. (1995) Antiemetic Therapy. In Kirk's Current Veterinary Therapy XII. Ed J. D. Bonagura. Philadelphia, W. B. Saunders. pp 679-684
15. 1 receptor. British Journal of Pharmacology 115, 84-94
16. YATES, B. J., MILLER, A. D. & LUCOT, J. B. (1998) Physiological basis and pharmacology of motion sickness: an update. Brain Research Bulletin 47, 395-406